Kenya Launches IMARA–BC to Transform Breast Cancer Care Nationwide
Nairobi, Kenya - - Kenya has taken a decisive step to transform breast cancer care with the launch of the IMARA–BC initiative — a three-year programme expanding access to timely diagnosis, treatment, and survivorship support for women across the country., AMPATH Kenya in partnership with the Ministry of Health and with support from The Pfizer Foundation, officially launched the Integrated Model for Access, Retention, and Advanced Breast Cancer Care (IMARA–BC) at Afya House, Nairobi.
The Cabinet Secretary for Health, Hon. Aden Duale, commended AMPATH, The Pfizer Foundation and all partners for advancing a coordinated, patient-centred approach that strengthens breast cancer care across the full continuum — from awareness and early detection to diagnosis, treatment, survivorship, and national policy alignment.
With support from The Pfizer Foundation, AMPATH and partners will expand digital diagnostics and screening, strengthen patient navigation and referral systems, build capacity of Community Health Promoters and healthcare providers, improve national cancer data systems, and support coordinated stakeholder engagement for long-term sustainability.
The initiative is part of The Pfizer Foundation’s global Action & Impact programme addressing breast cancer disparities across sub-Saharan Africa, including Kenya, Ethiopia, Ghana, Rwanda and Tanzania.
Together with partners including Moi Teaching and Referral Hospital, Moi University, the National Cancer Institute of Kenya and the National Cancer Control Programme, the initiative will advance timely, high-quality breast cancer care for women across Kenya.
The meeting was attended by Principal Secretary for Public Health and Professional Standards Ms. Mary Muthoni, Director General for Health Dr. Patrick Amoth, CEOs of MTRH Dr. Philip Kirwa and KEMSA Dr. Erjesa Waqo, as well as representatives from AMPATH, NCI, and NCCP.